A coalition of women's health advocates, consumer and public interestorganizations and academic researchers is currently touring Canada to gain support for its campaign for Health Canada not to lift its ban on direct-to-consumer advertising of prescription drugs as a result of its current review of the federal Food and Drug Act.
DTC drug advertising is poor public policy, says Barbara Mintzes, a leader of the Working Group on Women and Health Protection. Also on the tour is Peter Mansfield, described by the group as an international expert on DTC, who says: "expecting drug companies to be able to provide unbiased information about their drugs is like expecting proud parents to be able to provide unbiased information about the beauty of their children."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze